Abstract
Purpose
Nicorandil has dual properties and acts as a nitric oxide donor and an ATP-sensitive potassium (KATP) channel opener. Considering its pharmacological profile, nicorandil might exert protective effects on the brain as well as on the heart. The purpose of this study was to directly evaluate the effect of nicorandil on cerebral blood flow (CBF) in mice using a transcranial Doppler method.
Methods
Under general anesthesia, the nicorandil groups received a single-bolus intraperitoneal injection of the respective doses of nicorandil (1, 5, or 10 mg/kg), while the control group received vehicle only. CBF was measured using a transcranial Doppler flowmeter. NG-nitro-l-arginine methyl ester and glibenclamide were used to elucidate the underlying mechanisms.
Results
A single-bolus injection of 1 mg/kg of nicorandil increased the CBF (11.6 ± 3.6 vs. 0.5 ± 0.7%, p < 0.001) without affecting the heart rate and blood pressure. On the contrary, 5 and 10 mg/kg of nicorandil significantly decreased the cerebral blood flow by decreasing the mean blood pressure below the cerebral autoregulation range. The positive effect of 1 mg/kg of nicorandil on the cerebral blood flow was inhibited by co-administration of either NG-nitro-l-arginine methyl ester or glibenclamide.
Conclusions
A clinical dose of nicorandil increases CBF without affecting systemic hemodynamics. The positive effect of nicorandil on CBF is most likely caused via both the nitric oxide pathway and KATP channel opening.
Similar content being viewed by others
References
Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol. 1989;63:18J–24J.
IONA Study Group. Impact of nicorandil in angina: subgroup analyses. Heart. 2004;90:1427–30.
Matsuo H, Watanabe S, Segawa T, Yasuda S, Hirose T, Iwama M, Tanaka S, Yamaki T, Matsuno Y, Tomita M, Minatoguchi S, Fujiwara H. Evidence of pharmacologic preconditioning during PTCA by intravenous pretreatment with ATP-sensitive K+ channel opener nicorandil. Eur Heart J. 2003;24:1296–303.
Tarkin JM, Kaski JC. Vasodilator therapy: nitrates and nicorandil. Cardiovasc Drugs Ther. 2016;30:367–78.
Horinaka S. Use of nicorandil in cardiovascular disease and its optimization. Drugs. 2011;71:1105–19.
Heron-Milhavet L, Xue-Jun Y, Vannucci SJ, Wood TL, Willing LB, Stannard B, Hernandez-Sanchez C, Mobbs C, Virsolvy A, LeRoith D. Protection against hypoxic-ischemic injury in transgenic mice overexpressing Kir6.2 channel pore in forebrain. Mol Cell Neurosci. 2004;25:585–93.
Sun HS, Feng ZP, Miki T, Seino S, French RJ. Enhanced neuronal damage after ischemic insults in mice lacking Kir6.2-containing ATP-sensitive K+ channels. J Neurophysiol. 2006;95:2590–601.
Nakagawa I, Alessandri B, Heimann A, Kempski O. MitoKATP-channel opener protects against neuronal death in rat venous ischemia. Neurosurgery. 2005;57:334–40 (discussion 334–340).
Akai K, Wang Y, Sato K, Sekiguchi N, Sugimura A, Kumagai T, Komaru T, Kanatsuka H, Shirato K. Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels. J Cardiovasc Pharmacol. 1995;26:541–7.
Ishiyama T, Dohi S, Iida H, Akamatsu S, Ohta S, Shimonaka H. Mechanisms of vasodilation of cerebral vessels induced by the potassium channel opener nicorandil in canine in vivo experiments. Stroke. 1994;25:1644–50.
Iwata K, Iida H, Iida M, Takenaka M, Tanabe K, Fukuoka N, Uchida M. Nicorandil protects pial arterioles from endothelial dysfunction induced by smoking in rats. J Neurosurg Anesthesiol. 2013;25:392–8.
Inoue S, Kawaguchi M, Kurehara K, Sakamoto T, Kitaguchi K, Furuya H. Effect of mild hypothermia on nicorandil-induced vasodilation of pial arterioles in cats. Crit Care Med. 2001;29:2162–8.
Kobayashi S, Yamaguchi S, Okada K, Suyama N, Bokura K, Murao M. Effects of nicorandil on regional cerebral blood flow in patients with chronic cerebral infarction. Preliminary communication. Arzneimittelforschung. 1992;42:1086–9.
Rosner MJ, Rosner SD, Johnson AH. Cerebral perfusion pressure: management protocol and clinical results. J Neurosurg. 1995;83:949–62.
Yu D, Fan C, Zhang W, Wen Z, Hu L, Yang L, Feng Y, Yin KJ, Mo X. Neuroprotective effect of nicorandil through inhibition of apoptosis by the PI3K/Akt1 pathway in a mouse model of deep hypothermic low flow. J Neurol Sci. 2015;357:119–25.
Gantenbein M, Attolini L, Bruguerolle B. Kinetics of bupivacaine after nicorandil treatment in mice. J Pharm Pharmacol. 1996;48:749–52.
Gulati P, Singh N. Pharmacological evidence for connection of nitric oxide-mediated pathways in neuroprotective mechanism of ischemic postconditioning in mice. J Pharm Bioallied Sci. 2014;6:233–40.
Gu Y, Zheng G, Xu M, Li Y, Chen X, Zhu W, Tong Y, Chung SK, Liu KJ, Shen J. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. J Neurochem. 2012;120:147–56.
Shafaroodi H, Asadi S, Sadeghipour H, Ghasemi M, Ebrahimi F, Tavakoli S, Hajrasouliha AR, Dehpour AR. Role of ATP-sensitive potassium channels in the biphasic effects of morphine on pentylenetetrazole-induced seizure threshold in mice. Epilepsy Res. 2007;75:63–9.
Eguchi Y, Takahari Y, Higashijima N, Ishizuka N, Tamura N, Kawamura Y, Ishida H. Nicorandil attenuates FeCl(3)-induced thrombus formation through the inhibition of reactive oxygen species production. Circ J. 2009;73:554–61.
Hedna VS, Ansari S, Shahjouei S, Cai PY, Ahmad AS, Mocco J, Qureshi AI. Validity of laser Doppler flowmetry in predicting outcome in murine intraluminal middle cerebral artery occlusion stroke. J Vasc Interv Neurol. 2015;8:74–82.
Phillips SJ, Whisnant JP. Hypertension and the brain. The National High Blood Pressure Education Program. Arch Intern Med. 1992;152:938–45.
Niwa K, Kazama K, Younkin L, Younkin SG, Carlson GA, Iadecola C. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol. 2002;283:H315–23.
Brodmann M, Lischnig U, Lueger A, Stark G, Pilger E. The effect of the K+ agonist nicorandil on peripheral vascular resistance. Int J Cardiol. 2006;111:49–52.
Wolf DL, Ferry JJ, Hearron AE, Froeschke MO, Luderer JR. The haemodynamic effects and pharmacokinetics of intravenous nicorandil in healthy volunteers. Eur J Clin Pharmacol. 1993;44:27–33.
Waldman SA, Murad F. Cyclic GMP synthesis and function. Pharmacol Rev. 1987;39:163–96.
Nielsen-Kudsk JE, Boesgaard S, Aldershvile J. K+ channel opening: a new drug principle in cardiovascular medicine. Heart. 1996;76:109–16.
Horinaka S, Kobayashi N, Yagi H, Mori Y, Matsuoka H. Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure. J Cardiovasc Pharmacol. 2006;47:629–35.
Kaneko T, Saito Y, Hikawa Y, Yasuda K, Makita K. Dose-dependent prophylactic effect of nicorandil, an ATP-sensitive potassium channel opener, on intra-operative myocardial ischaemia in patients undergoing major abdominal surgery. Br J Anaesth. 2001;86:332–7.
Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27–31.
Zhang F, White JG, Iadecola C. Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J Cereb Blood Flow Metab. 1994;14:217–26.
Ito T, Yamakawa H, Bregonzio C, Terron JA, Falcon-Neri A, Saavedra JM. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke. 2002;33:2297–303.
Greene NH, Lee LA. Modern and evolving understanding of cerebral perfusion and autoregulation. Adv Anesth. 2012;30:97–129.
Seino S, Miki T. Physiological and pathophysiological roles of ATP-sensitive K+ channels. Prog Biophys Mol Biol. 2003;81:133–76.
Funding
This work was supported by the Japan Society for Promotion of Science (JSPS KAKENHI Grant number 17K11044).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Kotoda, M., Ishiyama, T., Mitsui, K. et al. Nicorandil increased the cerebral blood flow via nitric oxide pathway and ATP-sensitive potassium channel opening in mice. J Anesth 32, 244–249 (2018). https://doi.org/10.1007/s00540-018-2471-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-018-2471-2